文献速递艾滋病与性传播感染

HIV感染成人接种13价肺炎球菌结合疫苗后接种23价肺炎球菌多糖疫苗诱导的免疫原性与免疫记忆

Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
PubMed 文献 · J Infect Dis · 2018-01-01

40例接受抗逆转录病毒治疗且病毒载量检测不到的HIV血清阳性成人纳入研究,17例CD4+ T细胞计数≥400 cells/μL(A组),23例CD4+ T细胞计数200-399 cells/μL(B组),所有成人接种PCV13,1年后接种PPV23。接种引起PS抗体较基线显著升高(P < .001),B组PS14和PS3滴度均显著低于A组(P < .05)。PCV13后IgM+ MBC水平不变而sIg+ MBC显著升高,PPV23后IgM+ MBC显著降低而sIg+ MBC保持稳定。

要点

  • HIV感染成人接种PCV13后1年接种PPV23,PS抗体较基线显著升高(P < .001)。
  • CD4+ T细胞计数200-399 cells/μL组PS14和PS3抗体滴度均显著低于≥400 cells/μL组(P < .05)。
  • PPV23接种后IgM+ MBC显著降低,提示PPV23对PCV13相关免疫记忆有耗竭效应。

核心结论

  • PCV13接种12个月后接种PPV23改善了PCV13免疫原性。
  • PPV23接种后观察到的IgM+ MBC计数降低提示PPV23对PCV13相关免疫记忆有耗竭效应。

研究设计与样本

  • 40例接受抗逆转录病毒治疗且病毒载量检测不到的HIV血清阳性成人纳入研究。
  • 17例CD4+ T细胞计数≥400 cells/μL(A组),23例CD4+ T细胞计数200-399 cells/μL(B组)。
  • 所有成人接种PCV13,1年后接种PPV23。
  • 在每次疫苗接种前和接种后1个月测量IgM+ MBC、sIg+ MBC及针对PS14和PS3的抗体水平。

主要发现

  • 免疫接种引起PS抗体较基线水平显著升高(P < .001)。
  • B组PS14和PS3滴度均显著低于A组(P < .05)。
  • 接种PCV13后IgM+ MBC水平不变,而sIg+ MBC水平显著升高(PS14 P < .05,PS3 P < .001)。
  • 接种PPV23后IgM+ MBC水平显著降低,sIg+ MBC水平保持稳定。
  • PCV13接种后1个月基线IgM+与sIg+ MBC计数呈正相关,PPV23接种后未观察到该相关性。

关键数值与推荐

  • IgM+ MBC定义为多糖(PS)特异性CD19+CD10-CD27+CD21++IgM+ MBC。
  • sIg+ MBC定义为PS特异性CD19+CD10-CD27+CD21++IgM- MBC。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine-induced memory B-cell (MBC) subsets have distinct roles in the establishment of protective immunity; MBCs expressing nonswitched immunoglobulin M (IgM+ MBCs) replenish the MBC pool, whereas MBCs expressing isotype-switched immunoglobulin (sIg+ MBCs) differentiate into plasma cells upon antigen reencounter. We investigated immunogenicity and MBCs induced by combined 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPV23) in human immunodeficiency virus (HIV)-infected adults. METHODS: Forty HIV-seropositive adults receiving ART with undetectable viral loads were enrolled. Seventeen had a CD4+ T-cell count of ≥400 cells/μL (group A), and 23 had a CD4+ T-cell count of 200-399 cells/μL (group B). All adults received PCV13 and, 1 year later, PPV23. Levels of IgM+ MBCs (defined as polysaccharide [PS]-specific CD19+CD10-CD27+CD21++IgM+ MBCs) and sIg+ MBCs (defined as PS-specific CD19+CD10-CD27+CD21++IgM- MBCs) and antibodies against PS14 and PS3 were measured prior and 1 month after each vaccination. RESULTS: Immunization caused a significant increase in PS antibodies, compared with levels at baseline (P < .001). Group B achieved significantly lower titers than group A (P < .05 for both PS14 and PS3). After receipt of PCV13, levels of IgM+ MBCs were unchanged, whereas levels of sIg+ MBCs increased significantly (P < .05 for PS14 and P < .001 for PS3). In contrast, following PPV23 receipt, levels of IgM+ MBCs were significantly reduced, and levels of sIg+ MBCs remained stable. A positive correlation was observed between baseline IgM+ and sIg+ MBC counts 1 month after PCV13 receipt but not after PPV23 receipt. CONCLUSIONS: PPV23 receipt 12 months after PCV13 receipt improved PCV13 immunogenicity. The reduction in the IgM+ MBC count observed after PPV23 receipt suggests that PPV23 has a depleting effect on PCV13-associated immunological memory. CLINICAL TRIALS REGISTRATION: NCT03041051.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Farmaki PF, Chini MC, Mangafas NM, et al. Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults. J Infect Dis. 2018. PMID: 29722823. doi:10.1093/infdis/jiy135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。